You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The Cutting Edge Adalimumab Treatment for Pyoderma Gangrenosum
Michael P. Heffernan; Milan J. Anadkat; David I. Smith
Arch Dermatol 2007; 143: 306-308.
[Extract][Full text][PDF]
Observations Treatment of Atypical Nevi With Imiquimod 5% Cream
Najwa Somani; Magdalena Martinka; Richard I. Crawford; Jan P. Dutz; Jason K. Rivers
Arch Dermatol 2007; 143: 379-385.
[Abstract][Full text][PDF]
Evidence-Based Dermatology: Research Commentaries What Are the Risks of Serious Infections and Malignancies for Patients Treated With Anti-Tumor Necrosis Factor Antibodies?
The Cutting Edge Cinacalcet for the Treatment of Calciphylaxis
Maria R. Robinson; Joshua J. Augustine; Neil J. Korman
Arch Dermatol 2007; 143: 152-154.
[Extract][Full text][PDF]
Observations Psoriasis and Pustular Dermatitis Triggered by TNF- Inhibitors in Patients With Rheumatologic Conditions
Gillian C. de Gannes; Mehran Ghoreishi; Janet Pope; Anthony Russell; David Bell; Stewart Adams; Kamran Shojania; Magdalena Martinka; Jan P. Dutz
Arch Dermatol 2007; 143: 223-231.
[Abstract][Full text][PDF]
Inhibitors in Patients With Rheumatologic Conditions